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Background: The prevalence of type 2 diabetes has rapidly increased in the Taiwanese population with the
increasing prevalence of a sedentary lifestyle and high-calorie dietary intake. This study aims to determine the
annual trends of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to
2007.
Methods: A population-based study of all residents aged 20 years and over (12,191,076 in 2000 and 18,772,180 in
2007) enrolled in the National Health Insurance (NHI) program, the database of which was used to identify patients
diagnosed with type 2 diabetes. The annual prevalence and incidence of diagnosed type 2 diabetes were
estimated using the International Classification of Diseases, 9th Revision, Clinical Modification diagnostic codes
based on age, gender, insurance premium, and urbanization degree. Logistic regression was used to estimate the
odds ratios (OR) of risk factors, as well as to examine the trend in the annual prevalence or incidence of diagnosed
type 2 diabetes from 2000 to 2007.
Results: The crude annual prevalence of diagnosed type 2 diabetes increased significantly from 5.79% in 2000 to
8.30% in 2007. The increase was highest in 2007, among men, individuals aged ≥ 80 years, and individuals residing
in aging society areas [OR (95% CI): 1.416 (1.412–1.420), 1.033 (1.032–1.034), 31.810 (31.690–31.931), and 1.090
(1.085–1.094), respectively]. The crude incidence fluctuated throughout the study period, ranging from 7.72 per
1,000 in 2006 to 8.98 per 1,000 in 2000. The decrease was highest in 2006, among individuals with an insurance
premium ≥ median value [0.933 (0.925–0.942) and 0.810 (0.805–0.815), respectively]. The greatest increase was
among men, individuals aged 60 to 79 years, and individuals residing in aging society areas [1.150 (1.145–1.155),
15.452 (15.329–15.576), and 1.127 (1.113–1.142), respectively].
Conclusion: This study demonstrated the substantial increase in annual prevalence of diagnosed type 2 diabetes
among adults in Taiwan from 2000 to 2007. The incidence fluctuated between 2000 and 2007.
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Type 2 diabetes has rapidly increased in prevalence in
Asian populations along with the increasing prevalence of
a sedentary lifestyle and high-calorie dietary intake [1]. Dia-
betes develops at a younger age among Asian populations
than among Western populations, and the morbidity and
mortality associated with diabetes are becoming common
in young Asians [2,3]. Type 2 diabetes has also become an
important public health challenge among ethnic Chinese
populations, especially in Taiwan, mainland China, Hong
Kong, and Singapore, which comprise at least one-fifth of
the global population [4-7]. In Taiwan, the prevalence rates
of diabetes established from 1985 to 1996 were between
4.9% and 9.2% [4], which increased with age and varied
with gender, race, and ethnicity. The Nutrition and Health
Survey in Taiwan showed that the estimated prevalence
rates of type 2 diabetes among the 19–44, 45–64, and ≥ 65
age groups (in years) were 0.6%, 11.4%, and 22.0%, respect-
ively, among females and 1.1%, 7.0%, 7.2%, respectively,
among males from 1993 to 1996 [8]. Furthermore, the esti-
mated overall diabetes prevalence rates were 12.0% among
men and 8.0% among women from 2005 to 2008 [9].
Previous studies estimating the incidence of type 2 dia-
betes in Taiwan are few. Recent studies have estimated
that the overall five-year incidence among men and
women in Taiwan was 187.1 and 218.4, respectively, per
100,000 people from 1992 to 1996 [10]. From 1999 to
2004, the overall five-year incidence remained stable at 7.6
among men and 7.7–6.9 among women per 1,000 person-
years [11]. Furthermore, a previous study estimated the in-
cidence of type 2 diabetes in persons aged ≥20 years and
exempted from paying the National Health Insurance
(NHI) premium was 20.4 per 1,000 person-years [12].
Thus, contemporary data are needed to update the
existing demographics of diabetes in Taiwan.
Most prevalence estimates in Taiwan are based on rela-
tively small populations with limited nationwide represen-
tativeness. The estimates reflect conditions at least 10 years
ago or originate from studies using various methods to as-
certain type 2 diabetes. Although the estimates of incidence
in Taiwan are based on large samples, new data are needed
to obtain information on existing conditions. In addition,
time trend analyses of the annual prevalence and incidence
of type 2 diabetes for a longer period using standardized
methods have never been reported. The present study aims
to conduct time trend analyses of the prevalence and inci-
dence of type 2 diabetes in Taiwan from 2000 to 2007 in




The Taiwanese government launched the NHI program in
March 1995, and 22.60 million out of the 22.96 milliontotal population were enrolled in this program in 2007
[13]. After the implementation of the NHI program in
1995, about 98% of Taiwan’s population was covered. By
the end of 2008, more than 99% was covered by the NHI
program [14]. The NHI Bureau had contracts with 97% of
hospitals and 92% of clinics all over the nation [15]. Expert
reviews of a random sample of every 50–100 ambulatory
and inpatient claims in each hospital and clinic were
conducted quarterly to enhance the validity of the claims
data. A severe penalty is imposed by the NHI Bureau on
every false diagnosis report. The current study used the
1996 to 2007 registry datasets for beneficiaries, outpatient
care by visits, and inpatient care by admission. Every indi-
vidual in Taiwan has a unique personal identification
number (PIN). The data on patient identities were scram-
bled cryptographically by the National Health Insurance
Research Database (NHIRD) to protect patient privacy.
All NHI datasets can be interlinked with the PIN of each
individual. Registry files for beneficiaries were used to de-
fine the population for each year. The exclusion criteria
discounted individuals who were not insured and who
were younger than 20 years. The study population for each
specific year was defined. These datasets are publicly avail-
able and were released by the institutes of the Taiwanese
government.
Ascertainment of diagnosed, and incident and prevalent
cases
The population of patients diagnosed with type 2 diabetes
was identified from diabetes datasets that contain original
claims data for outpatient visits and inpatient admissions.
Claims datasets from 2000 to 2007 were searched to iden-
tify any outpatient visit or inpatient admission with dia-
betes as one of the diagnoses (International Classification
of Diseases, 9th Revision, Clinical Modification, ICD-
9-CM code 250). Patients were classified as having type 2
diabetes and were thus included in the analysis if they had
at least three ambulatory claims with a diagnosis of ICD-
9-CM code 250 or A-code A181, or at least one inpatient
claim with diabetes as one of the discharge diagnoses
(ICD-9-CM code 250) during the specific year period.
Patients who were type 2 diabetic but younger than
20 years, who were in gestation (ICD-9 code 6480), or
who were type 1 diabetic (ICD code 250.×1, 250.×3) were
excluded from this study.
An incident case was ascertained after confirming that
the patient did not meet the criteria of type 2 diabetes in
the claims datasets of the specific calendar year prior to
his/her diabetes diagnosis. The claims datasets contained
all types of health care services since 1996. Thus, the
incident cases identified after 1 January 2000 had at least
a four-year diabetes-free observation period. Incident
cases were ascertained until 31 December 2007. The
hospital admission date or the date of the first outpatient
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first, was used as the date of incident event. Patients
remained as prevalent cases regardless of whether or not
they had diabetes diagnosis claims in the subsequent cal-
endar year, as long as they remained in the datasets.
Socio-demographic and urbanization levels of residential
area
The socio-demographic factors studied included age,
gender, and insurance premium. Age was categorized
into four levels: 20–39, 40–59, 60–79, and ≥ 80 (in
years). Insurance premiums were categorized into three
levels: dependent population based on insurance pre-
mium, insurance premium less than its median value,
and insurance premium greater than or equal to its
median value. The dependent population consisted of
individuals not in the labor force, such as students,
housewives, and retirees. The insurance premium of an
individual was determined by his/her work salary. The
median values of the insurance premium were 19,400,
19,200, 16,500, and 21,000 Taiwan dollars in 2000, 2001,
and 2003–2006, 2002, and 2007, respectively.
The residential areas of the study subjects, which cov-
ered 365 Taiwan townships, were classified into seven
levels of urbanization according to the method devel-
oped by Liu et al. [16]. The seven levels of urbanization
were high-density urban area, medium-density urban
area, newly developed area, general area, aging society
area, rural area, and non-developed area (seclusion area).
The variables used in developing the township stratifica-
tion for urbanization level consisted of the population
density (people/km2), population ratio of people with an
educational level of college or above, population ratio of
elder people over 65 years old, population ratio of agri-
cultural workers, and the number of physicians per
100,000 people, among others.
Statistical analysis
The prevalence and incidence rates of patients clinically
diagnosed with type 2 diabetes from 2000 to 2007 were
estimated. The estimates of the annual prevalence rates
according to age, gender, insurance premium, and urba-
nization level were obtained by dividing the number of
prevalent cases of diagnosed type 2 diabetes identified in
the NHI datasets by the total number of residents en-
rolled in the NHI program in a given year. The annual
incidence rates of clinically diagnosed type 2 diabetes
were estimated according to socio-demographic category
by dividing the number of newly diagnosed type 2 dia-
betes cases by the total number of insured individuals
who did not have type 2 diabetes at the beginning of
the year in the NHI program. Annual incidence was
expressed as per 1,000 residents of the source popula-
tion in a given year.The prevalence and incidence rates of diagnosed type
2 diabetes were adjusted using a direct standardization
method that employs the age- and gender-specific rates of
each year and age and gender distributions of the study
population for the year 2000. The weights for the 20–39,
40–59, 60–79, and ≥ 80 age groups were 20.93%, 19.44%,
8.84%, and 1.17%, respectively, for men and 21.43%,
19.32%, 7.65%, and 1.21%, respectively, for women.
Multivariate logistic regression models were used to
analyze the trends in prevalence and incidence over time
while controlling the changes in the underlying age, sex,
insurance premium, and urbanization level distributions.
The dependent variable was diagnosed diabetes preva-
lence/incidence (diabetes = 1; non-diabetes = 0), and the
categorical predictor variables were entered for the year
(2000 as the reference), age group (20–39 years as the
reference), gender (female as the reference), insurance
premium (dependent population as the reference), and
urbanization level (high-density urban area as the refer-
ence). If a time trend was observed, the rates of change
in prevalence were analyzed by replacing the set of cat-
egorical variables for the calendar year with a continuous
variable defined as time (in years). The terms of the age
group variable multiplied by the time variable were
added as covariates to examine the effects of the inter-
action between age group and time, as well as to investi-
gate whether the rates of change over time in prevalence
or incidence differed across age groups. A statistically
significant interaction between time and a given age
group indicated that the rate of change in prevalence/
incidence differed over time compared with the refer-
ence age group (60 to 69 years).
Results
A total of 1,557,494 patients in the NHIRD were identi-
fied as prevalent diagnosed cases from 2000 to 2007.
The mean age of the prevalent diagnosed cases was 62.6,
with a standard deviation (SD) of 13.3. The source popu-
lation for which the prevalence was estimated was
12,191,076 in 2000 and 18,772,180 in 2007.
A 43.4% increase (from 5.8% to 8.3%) in the crude annual
prevalence of diagnosed type 2 diabetes occurred from
2000 to 2007 (Table 1). After the direct standardization of
the population in 2000, the annual standardized prevalence
rates, as well as the discrepancy between crude and stan-
dardized annual prevalence rates, increased over time.
Higher annual prevalence rates were observed in the older
age, dependent population, and aging society area groups.
The annual prevalence rates increased from 5.9% to 8.0%
among women and from 5.7% to 8.6% among men. The
rates were higher among females before 2002, but the num-
bers decreased thereafter.
Significant interactions in the annual prevalence rates
were observed between time and age groups for both
Table 1 Prevalence and incidence of type 2 diabetes in Taiwan
2000 2001 2002 2003 2004 2005 2006 2007
Prevalence rates of type 2 diabetes
Prevalent cases 706,444 795,650 906,794 1,045,892 1,166,113 1,294,594 1,421,940 1557494
Age (year) 62.1±12.8 62.1±12.9 62.1±13.0 62.0±13.2 62.3±13.3 62.8±13.6 63.2±13.7 63.7±13.9
Total population 12,191,076 13,122,056 14,543,692 16,797,716 17,284,273 17,891,631 18,327,156 18,772,180
Prevalence rate (%) 5.8 6.1 6.2 6.2 6.8 7.2 7.8 8.3
Standardized prevalence rate (%) 5.8 6.2 6.5 6.8 7.3 7.8 8.2 8.5
Age
20–39 0.6 0.6 0.6 0.6 0.7 0.7 0.8 0.8
40–59 5.6 6.0 6.3 6.5 7.0 7.3 7.7 8.0
60–79 17.6 18.7 19.8 20.8 22.2 23.6 24.8 25.9
≥80 16.4 18.0 19.6 21.2 23.3 25.4 27.2 28.9
Sex
Female 5.9 6.1 6.2 6.1 6.6 7.0 7.5 8.0
Male 5.7 6.1 6.3 6.4 6.9 7.4 8.0 8.6
Insurance premium
Dependent population 8.3 8.5 8.8 8.9 9.5 10.5 11.5 12.5
< Median 5.3 6.8 5.4 6.8 7.4 7.8 8.3 8.6
≧Median 5.2 3.5 5.7 3.5 3.8 4.0 4.2 4.3
Urbanization level
High-density urban area 5.1 5.3 5.5 5.4 5.9 6.3 6.8 7.3
Medium-density urban area 5.8 6.0 6.2 6.2 6.7 7.2 7.7 8.3
Newly developed area 5.4 5.6 5.8 5.8 6.2 6.7 7.1 7.6
General area 6.6 7.0 7.2 7.4 8.0 8.6 9.2 9.8
Aging society area 8.6 9.1 9.5 10.0 10.8 11.8 12.7 13.6
Rural area 7.4 7.9 8.3 8.7 9.6 10.5 11.4 12.3
Non-developed area 6.9 7.4 7.7 8.0 8.8 9.5 10.2 11.0
Incidence rates of type 2 diabetes
Incident cases 94,895 99,571 108,261 112,737 136,891 128,702 129,702 136,914
Age (year) 59.5±13.7 59.2±13.7 59.1±13.8 58.8±13.9 58.2±14.1 58.5±14.2 58.2±14.1 58.3±14.0
Population at risk 10,563,201 11,151,246 12,075,839 13,574,064 15,858,527 16,379,127 16,807,297 17,147,703
Incidence rate (/1000) 9.0 8.9 9.0 8.3 8.6 7.9 7.7 8.0
Standardized incidence rate (/1000) 9.0 9.1 9.3 8.9 9.8 8.9 8.7 8.9
Age
20–39 1.5 1.5 1.5 1.4 1.5 1.4 1.4 1.4
40–59 9.8 10.1 10.3 9.9 11.0 9.9 9.9 10.3
60–79 23.9 23.8 24.5 23.5 25.5 23.7 22.8 23.3
≥80 25.1 24.8 25.5 24.6 25.7 22.9 20.0 19.2
Sex
Female 8.6 8.4 8.3 7.6 7.9 7.2 7.0 7.3
Male 9.4 9.5 9.7 9.0 9.4 8.6 8.4 8.7
Insurance premium
Dependent population 11.3 11.0 11.1 10.4 11.1 10.3 10.1 10.5
< Median 8.7 10.0 8.2 9.2 9.4 8.5 8.3 8.4
≥Median 8.4 6.1 8.5 5.6 5.8 5.3 5.3 5.5
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Table 1 Prevalence and incidence of type 2 diabetes in Taiwan (Continued)
Urbanization level
High-density urban area 7.9 8.0 8.0 7.3 7.8 7.1 7.0 7.2
Medium-density urban area 9.0 8.9 9.0 8.2 8.6 7.8 7.8 8.0
Newly developed area 8.3 8.3 8.4 7.9 8.1 7.3 7.1 7.4
General area 10.2 10.0 10.1 9.6 9.9 8.9 8.7 9.2
Aging society area 12.9 13.1 12.9 12.6 12.9 12.1 12.1 12.5
Rural area 11.4 11.4 11.6 10.8 12.1 11.5 11.1 11.6
Non-developed area 10.5 10.4 10.8 10.5 10.9 10.2 9.8 10.1
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in diabetes prevalence rates were largest in the age
group ≥ 80 years, followed by the 60–79, 40–59, and
20–39 age groups. From 2000 to 2007, annual preva-
lence increased by 76.7% (from 17.7% to 31.3%) among
females and by 78.7% (from 14.9% to 26.6%) among
males in the 80 years and over group; by 39.6% (from
19.5% to 27.3%) among females and 55.3% (from 15.8%
to 24.6%) among males in the 60–79 group; by 29.4%
(from 5.3% to 6.9%) among females and 55.4% (from
5.9% to 9.2%) among males in the 40–59 group; and by
26.4% (from 0.5% to 0.7%) among females and 47.0%
(from 0.7% to 1.0%) among males in the 20–39 group.
The number of annual incident cases of diagnosed
type 2 diabetes increased from 94,895 to 136,914 from
2000 to 2007, as well (Table 1). The mean age of inci-
dence case patients was 58.7, with a SD of 13.9. The
crude annual incidence fluctuated between 7.7 per 1,000
and 9.0 per 1,000 throughout the study duration. After
the direct standardization of the Taiwanese populationFigure 1 Time trends in the prevalence of type 2 diabetes stratified bin 2000, the annual incidence rates gradually increased
from 2000 to 2002, and then fluctuated thereafter.
After multivariate adjustment, the prevalence of type 2
diabetes was found to be significantly associated with
age [OR (95% CI): 10.0 (10.0–10.0), 30.2 (31.7–31.9),
and 31.8 (31.7–31.9) for the age groups 40–59, 60–79,
and ≥ 80 years, respectively; Table 2]. Prevalence was
generally high among males [1.0 (1.0–1.0)] and among
individuals living in medium-density urban areas [1.1
(1.1–1.1)], newly developed areas [1.0 (1.0–1.0)], general
areas [1.0 (1.0–1.0)], aging society areas [1.1 (1.1–1.1)],
rural areas [1.0 (1.0–1.0)], and non-developed areas [1.1
(1.1–1.1)]. However, prevalence was lower among indi-
viduals with an insurance premium < median [0.7 (0.7–
0.7)] and ≥ median [0.8 (0.8–0.8)]. The annual incidence
rate fluctuated instead of following a linear trend. Thus,
considering time as an ordinal variable, the annual in-
cidence rate was not significant. The incidence rates
among males were higher [1.2 (1.1–1.2)], especially
among the 60–79 [15.5 (15.3–15.6)], middle insurancey age in females.
Figure 2 Time trends in the prevalence of type 2 diabetes stratified by age in males.
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1.1)] groups (Table 3).
Discussion
The current study used the nationwide NHI claims data
to estimate the annual prevalence and incidence of type
2 diabetes diagnosed from 2000 to 2007. Increases in the
prevalence rate were observed in both crude age- and
gender-standardized annual prevalence rates from 2000
to 2007. The annual standardized incidence rates fluctu-
ated throughout the period.
The results showed that the annual prevalence of type
2 diabetes continued to rise throughout the study period.
The World Health Organization (WHO) predicted that
a 39% increase in the global prevalence of diabetes
would occur between 2000 and 2030. However, a 43.35%
increase in prevalence has already occurred over an
eight-year period in Taiwan. During the same period, the
crude incidence rate did not exhibit a linear growth
trend. Instead, it decreased slightly since 2005. Thus, the
increase in the prevalence of type 2 diabetes may be
partly explained by better diabetes care and longer
survival.
The cross-sectional studies in various areas of Taiwan
included the Ann-Lo district in northern Taiwan in 1988–
1990 [17], the Kin-Hu and Kinmen offshore islands in
1991–1994 [18], Pu-li township in central Taiwan in
1987–1988 and 1991–1992 [19], Tainan city in southern
Taiwan in 1996 [18], and the Penghu offshore islands in
1995–1997 [20] with a prevalence of 5.6%–9.0%. All these
studies were based on small samples collected in restricted
areas; thus, their estimates may not be reliable and valid
for national estimates. In addition, these studies were
conducted before 2000. After 2000, Chang et al. [11] used
the NHI database, which consisted of 15 million individ-
uals from 23 million insured people registered in the NHIprogram of Taiwan, to estimate the prevalence of type 2
diabetes. The current study made use of 23 million in-
sured people under the NHI program. The estimated
prevalence and incidence using the same definition of type
2 diabetes and datasets were found to be similar to those
of Chang et al. [11]. The present study is more reliable
and provides more precise prevalence and incidence esti-
mates because of the larger sample size. Furthermore, this
study provides prevalence and incidence rates across sev-
eral socio-demographic subgroups. Compared with the
prevalence rates for the same year, the prevalence based
on our findings is lower than those for India (12.1% in
2000), Sri Lanka (10.3% in 2006), and Korea (7.6% in
2001); closer to those for China (6.1% in 2002), Thailand
(6.7% in 2004), and the Philippines (6.5% in 2004); and
higher than that for Vietnam (3.8% in 2001) [2,6,7].
Previous studies have shown that there is an increasing
trend in the prevalence of type 2 diabetes globally; spe-
cifically, prevalence increased by 28.3% among men and
25.9% among women in Sweden from 1972 to 2001 [21],
48% in America from 1990 to 1998 [22], 47% in England
from 1994 to 2001 [23], 69% in Canada from 1995 to
2005 [24], and 38% among men and 25% among women
in Taiwan from 1999 to 2004 [11]. The findings in the
present study further demonstrated that the prevalence
of type 2 diabetes also increased from 2005 to 2007, with
a greater increase among men, which was consistent
with the findings of previous studies [21,23]. Previous
studies examining the incidence trend of type 2 diabetes
in Taiwan showed that the incidence rates among both
men and women increased from 1992 to 1996 in Taiwan
[10]. However, the incidence rates remained stable
among men and slightly decreased among women from
1999 to 2004, after considering age and gender [11].
Thus, the trend toward a decreasing incidence among
women and the stable incidence rate among men may
Table 2 Multivariate-adjusted relative risk of annual prevalence of type 2 diabetes rates for sex, age, time, insurance
premium, and urbanization level
Variable Crude relative risk (95% CI) Multivariate-adjusted relative risk (95% CI)a
Logistic regression model-type 2 diabetes prevalence
2000 1 1
2001 1.1 (1.0–1.1)*** 1.0 (1.0–1.0)***
2002 1.1 (1.1–1.1)*** 1.1 (1.1–1.1)***
2003 1.1 (1.1–1.1)*** 1.1 (1.1–1.1)***
2004 1.2 (1.2–1.2)*** 1.2 (1.2–1.2)***
2005 1.3 (1.3–1.3)*** 1.3 (1.3–1.3)***
2006 1.4 (1.3–1.4)*** 1.4 (1.4–1.4)***
2007 1.4 (1.4–1.4)*** 1.4 (1.4–1.4)***
Sex




40–59 9.9 (9.9–9.9)*** 10.0 (10.0–10.0)***
60–79 31.5 (31.4–31.6)*** 30.2 (30.1–30.3)***
≥ 80 34.1 (34.0–34.2)*** 31.8 (31.7–31.9)***
Insurance premium
Dependent population 1 1
<Median 0.7 (0.7–0.7)*** 0. 9 (0.9–0.9)***
≥Median 0.4 (0.4–0.4)*** 0.8 (0.8–0.8)***
Urbanization level
High-density urban area 1 1
Medium-density urban area 1.1 (1.135–1.139)*** 1.1 (1.1–1.1)***
Newly developed area 1.0 (1.046–1.050)*** 1.0 (1.0–1.0)***
General area 1.3 (1.330–1.336)*** 1.0 (1.0–1.0)***
Aging society area 1.8 (1.8–1.8)*** 1.1 (1.1–1.1)***
Rural area 1. 6 (1.6–1.6)*** 1.0 (1.0–1.0)***
Non-developed area 1.4 (1.4–1.5)*** 1.0 (1.0–1.1)***
***: p < 0.001.
a: Modeled as an ordinal variable in a separate multivariate model with insurance premium, sex, age, insurance premium, and urbanization degree.
CI: confidence interval.
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women that was observed after 2002.
The initial higher prevalence rates among females before
2002 and the subsequent decrease were supported by a
previous study, which compared two nutrition and health
surveys from 1993–1996 and 2005–2008 [9]. The preva-
lence of diabetes in women was 5.5% in 1993–1996 and
8.0% in 2005–2008, whereas that in men was 3.2% in
1993–1996 and 12.0% in 2005–2008. This trend may be
explained by the increased prevalence of obesity in men,
which saw an increase from 33.4% in 1993–1996 to 51.0%
in 2005–2008; however, obesity among women remained
relatively stable, increasing from 33.5% in 1993–1996 to
35.9% in 2005–2008. The increased consumption of cakes,sweets, and sugary drinks, as well as the increased prolifer-
ation of a sedentary lifestyle, may have lead to this increase
in obesity [9].
Of note, a decline in type 2 diabetes prevalence among
individuals with an insurance premium greater than or
equal to a median value over the period of observation
was observed, which is consistent with the data reported
by the International Diabetes Federation [25]. This socio-
economically advantaged subgroup also experienced the
greatest decline in incidence rate, which is similar to the
findings reported by Hsu et al. [12], who indicated that
poverty is associated with higher diabetes incidence.
Increasing levels of obesity in the general population
in the past two decades are believed to be one of the
Table 3 Multivariate-adjusted relative risk of annual incidence rates of type 2 diabetes for sex, age, time, insurance
premium, and urbanization level
Variable Crude relative risk (95% CI) Multivariate-adjusted relative risk (95% CI)
Logistic regression model-type 2 diabetes incidence
2000 1 1
2001 1.0 (1.0–1.0) 0.9 (0.9–1.0)***
2002 1.0 (1.0–1.0) 1.0 (1.0–1.0)***
2003 0.9 (0.9–0.9)*** 0.9 (0.9–1.0)***
2004 0.9 (0.9–0.9)*** 1.0 (1.0–1.1)***
2005 0.9 (0.9–0.9)*** 0.9 (0.9–0.9)***
2006 0.9 (0.9–0.9)*** 0.9 (0.9–0.9)***
2007 0.9 (0.9–0.9)*** 0.9 (0.9–0.9)***
Sex




40–59 6.9 (6.9–7.0)*** 7.0 (6.9–7.1)***
60–79 16.2 (16.1–16.3)*** 15.5 (15.3–15. 6)***
≥80 15.6 (15.4–15.8)*** 14.9 (14.7–15.0)***
Insurance premium
Dependent population 1 1
<Median 0.8 (0.8–0.8)*** 0.9 (0.9–0.9)***
≥Median 0.6 (0.6–0.6)*** 0.8 (0.8–0.8)***
Urbanization level
High-density urban area 1 1
Medium-density urban area 1.1 (1.1–1.1)*** 1.1 (1.1–1.1)***
Newly developed area 1.0 (1.0–1.0)*** 1.0 (1.0–1.0)***
General area 1.3 (1.3–1.3)*** 1.0 (1.0–1.1)***
Aging society area 1.7 (1.7–1.7)*** 1.1 (1.1–1.1)***
Rural area 1.5 (1.5–1.5)*** 1.1 (1.1–1.1)***
Non-developed area 1.4 (1.4–1.4)*** 1.1 (1.1–1.1)***
***: p < 0.001.
CI: confidence interval.
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type 2 diabetes in Asia [26,27]. The Department of
Health in Taiwan has implemented many health promo-
tion programs in communities and workplaces in the
past 10 years for the prevention of chronic diseases [15].
The major component of these promotion programs is
an increase in the level of physical activity of residents
in Taiwan. The protective effects of physical activities in-
clude improved body composition, glucose tolerance,
and insulin sensitivity [28,29], and this may have con-
tributed to the decline in the incidence of type 2 dia-
betes since 2004, as determined in the present study.
The present study has four strengths. First, nationwide
data with a large sample size was used, which emphasizedthe prevalence and incidence trends with a standardized
method to define type 2 diabetes. Second, the NHI pro-
gram in Taiwan provides continuing universal coverage
for the entire population, which avoids selection bias.
Third, NHI datasets were used, which eliminated the need
to minimize the numbers of subjects in the cohorts lost to
follow-up. In addition, a large sample of geographically
dispersed patients was easily obtained. Finally, a large
number of study subjects facilitated the age- and sex-
stratified analyses with an ample sample size to satisfy
requirements.
Nevertheless, the current study also has several limita-
tions. First, some cases of type 1 diabetes may have been
falsely classified as type 2 diabetes. Diabetic patients
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http://www.biomedcentral.com/1471-2458/13/318aged 20 years and over were included, and individuals
with type 1 diabetes, as defined by the ICD-9 code, were
excluded to minimize the misclassification. Second, the
study depended exclusively on claims data, which may
have resulted in potential intentional or unintentional
disease misclassification bias. Patients with at least three
ambulatory claims or at least one inpatient claim with a
diagnosis of type 2 diabetes were included during the
specific year period to minimize potential misclassifica-
tion. Thus, the estimates of prevalence and incidence
may be underestimated. Finally, the body mass index,
waist circumference, blood pressure, smoking history,
family history of diseases, and laboratory test results
were not available in the claims database. Thus, combin-
ing this information with the discussion on the preva-
lence and incidence of type 2 diabetes was beyond the
scope of this study.
Diabetes is associated with an increased risk of co-
morbidity, such as cancer [30], dementia [31], and
Parkinson’s disease [32]. Previous studies indicated that the
cancer incidence density increases by 2.12, 2.80, 4.13, 2.10,
and 2.58-fold for total cancer, colorectal cancer, hepatocel-
lular cancer, pancreatic cancer, and dementia, respectively,
for diabetes patients without anti-hyperglycemic medica-
tion [30,31]. Considering the time trend of the prevalence
of type 2 diabetes indicated in our study, we would esti-
mate that the number of incident cases of total cancer,
colorectal cancer, hepatocellular cancer, pancreatic cancer,
and dementia would increase by 4391, 1083, 1568, 229,
and 6196, respectively, based on the risk difference be-
tween individuals without diabetes and those with diabetes
but no anti-hyperglycemic medication, as reported by Lee
et al. [30] and Hsu et al. [31]. Cancer and depression pre-
vention may be enhanced by the primary prevention of
diabetes mellitus or diabetes mellitus medication [30-32].
Conclusion
The NHI claims data used in this study showed that the
annual prevalence of type 2 diabetes increased in Taiwan
from 2000 to 2007, whereas the annual standardized in-
cidence fluctuated throughout the study period. Public
health professionals are recommended to plan appropri-
ate health promotion programs, such as exercise and a
healthy diet, for men, individuals aged 40 years and over,
and residents of areas with lower levels of urbanization.
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